Inclusion criteria: This registry will make it possible to describe real life management of patients with rare actionable fusions (including RET) and to better understand these cancers. In addition of clinical data from the medical files, a quality of life questionnaire (QLQ-C30) will be complete at inclusion, at each new treatment and then every 6 months. The patients will be followed for a period of at least 2 years after the inclusion.
Sponsor/Collaborator: Centre Leon Berard
Contact and Locations:
Name: Julien Bollard
Phone Number: 04 78 78 28 28
Email: julien.bollard@lyon.unicancer.fr
Phases: Observational
NCT Number: NCT04921553
Status: Recruiting
